Advertisement

Reactions Weekly

, Volume 1780, Issue 1, pp 305–305 | Cite as

Secukinumab

Ulcerative colitis and inflammatory bowel disease: 3 case reports
Case report
  • 47 Downloads

Reference

  1. Vernero M, et al. New Onset of Inflammatory Bowel Disease in Three Patients Undergoing IL-17A Inhibitor Secukinumab: A Case Series. American Journal of Gastroenterology 114: 179-180, No. 1, Jan 2019. Available from: URL: http://doi.org/10.1038/s41395-018-0422-z - ItalyCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations